Panel Discussion: Establishing a Correlation Between Potency & Clinical Efficacy
Time: 2:30 pm
day: Conference Day One - Track A - PM
Details:
• What should we be measuring beyond IFN-gamma? What about cytotoxicity, proliferation, or others?
• What measure(s) correlates best with clinical efficacy in T cell products?
• If we can’t correlate with clinical efficacy, what should we be concerned with?
